Baricitinib Preserves Beta Cell Function in Young Adults With Recent-Onset T1D Read more about Baricitinib Preserves Beta Cell Function in Young Adults With Recent-Onset T1D
Weekly Efsitora Improves Treatment Satisfaction and Reduces Burden in T2D Read more about Weekly Efsitora Improves Treatment Satisfaction and Reduces Burden in T2D
Dapagliflozin Reduces Renal Glucose Uptake and Preserves Kidney Function in Type 2 Diabetes Tags SGLT-2 Inhibitor Read more about Dapagliflozin Reduces Renal Glucose Uptake and Preserves Kidney Function in Type 2 Diabetes
SGLT2 Inhibitor Use After 80 Linked to Higher Discontinuation in Type 2 Diabetes Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitor Use After 80 Linked to Higher Discontinuation in Type 2 Diabetes
SGLT2 Inhibitors Linked to Higher Phimosis Risk in Men with Type 2 Diabetes Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Linked to Higher Phimosis Risk in Men with Type 2 Diabetes
Once-Weekly GZR4 Demonstrates Comparable Efficacy to Daily Insulin Degludec in Type 2 Diabetes Read more about Once-Weekly GZR4 Demonstrates Comparable Efficacy to Daily Insulin Degludec in Type 2 Diabetes
Once-Weekly Efsitora with Fixed-Dose Titration Achieves Comparable Glycemic Control to Daily Glargine Read more about Once-Weekly Efsitora with Fixed-Dose Titration Achieves Comparable Glycemic Control to Daily Glargine
SGLT2 Inhibitor Use Soars in Older Adults With Frailty in the UK Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitor Use Soars in Older Adults With Frailty in the UK
Once-Weekly GZR4 Shows Superior Glycemic Control Compared to Daily Insulin Degludec Read more about Once-Weekly GZR4 Shows Superior Glycemic Control Compared to Daily Insulin Degludec
SGLT2 Inhibitors Reduce Mortality in Patients with Type 2 Diabetes on Steroids Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Reduce Mortality in Patients with Type 2 Diabetes on Steroids